Weilert Frank
Department of Gastroenterology, Waikato Hospital, Pembroke Street, Hamilton, 3200, New Zealand,
Surg Endosc. 2014 Nov;28(11):3193-9. doi: 10.1007/s00464-014-3588-5. Epub 2014 May 31.
EUS-guided biliary drainage (EUS-BD) is technically challenging but alternative method of therapeutic intervention when ERCP fails.
Assess the feasibility, safety and risks of EUS-BD with intra-hepatic biliary access and anterograde interventions using an algorithm to increase flexibility of interventions, limit adverse events and improve procedural time.
Prospective observational cohort study.
21 consecutive patients underwent EUS-BD drainage for failed ERCP.
Technical and clinical success rates with adverse event rate using simplified algorithm.
Patient recruitment from June 2011-October 2013; mean age of 67.4 years, predominantly male (70.5 %) with pancreatic cancer (52.4 %), cholangiocarcinoma (14.3 %), other malignant biliary obstruction (9.5 %) and benign biliary obstruction (23.8 %). Prior interventions included failed ERCP in 18/21 (85.7 %) while 3/21 (14.3 %) had primary EUS-BD. Anterograde cholangiogram was achieved in all patients. Technical success was achieved in 20/21 (95.2 %) with clinical success was achieved in 19/21 (90.4 %). Placement of access wire was across the ampulla in 10/20 (50 %) and into CBD or contra-lateral IHD in 10/20 (50 %). Tract dilatation was accomplished in 17/20 (85 %) but required completion using intra-hepatic needle knife in 3/20 (15 %). Anterograde interventions were performed in 16/20 (80 %) but crossover to rendezvous in 3/20 (15 %) or choledochoduodenostomy 1/20 (5 %). Three patients 3/21 (14.3 %) also had endoscopic duodenal SEMS placement to relieve duodenal obstruction. Two patients (9.5 %) had post-procedural bile leak and pain.
EUS-guided anterograde biliary drainage using the intra-hepatic access route has high technical and clinical success with low adverse rate. We would promote a simplified standardized algorithm, which gives flexibility of direct anterograde interventions.
内镜超声引导下胆道引流术(EUS-BD)技术难度较大,但在经内镜逆行胰胆管造影术(ERCP)失败时是一种替代性治疗干预方法。
采用一种算法评估经肝内胆管入路和顺行干预的EUS-BD的可行性、安全性和风险,以增加干预的灵活性、限制不良事件并缩短操作时间。
前瞻性观察队列研究。
21例连续患者因ERCP失败接受EUS-BD引流。
使用简化算法的技术成功率、临床成功率及不良事件发生率。
2011年6月至2013年10月招募患者;平均年龄67.4岁,男性居多(70.5%),患有胰腺癌(52.4%)、胆管癌(14.3%)、其他恶性胆道梗阻(9.5%)和良性胆道梗阻(23.8%)。既往干预措施包括18/21(85.7%)患者ERCP失败,3/21(14.3%)患者直接接受EUS-BD。所有患者均成功进行了顺行胆管造影。20/21(95.2%)患者技术成功,19/21(90.4%)患者临床成功。10/20(50%)患者的导丝穿过壶腹,10/20(50%)患者的导丝进入胆总管或对侧肝内胆管。17/20(85%)患者完成了通道扩张,但3/20(15%)患者需要使用肝内针刀完成。16/20(80%)患者进行了顺行干预,但3/20(15%)患者转为会师操作,1/20(5%)患者进行了胆总管十二指肠吻合术。3例患者(3/21,14.3%)还进行了内镜十二指肠自膨式金属支架置入术以缓解十二指肠梗阻。2例患者(9.5%)术后出现胆漏和疼痛。
经肝内入路的EUS引导顺行胆道引流术技术成功率和临床成功率高,不良率低。我们推荐一种简化的标准化算法,该算法可灵活进行直接顺行干预。